Johnson & Johnson vs Samsung Electronics Co., Ltd.: Strategic Comparison

This in-depth comparison examines Johnson & Johnson and Samsung Electronics Co., Ltd. across revenue, market value, business model, competitive positioning, and long-term growth strategy. Whether you are researching Johnson & Johnson on its own, evaluating Samsung Electronics Co., Ltd., or weighing the two companies side by side, the breakdown below highlights where each company leads and where the gap between Johnson & Johnson and Samsung Electronics Co., Ltd. is widest.

On the headline numbers, Johnson & Johnson reports annual revenue of $94.2B against $233.3B for Samsung Electronics Co., Ltd., while their respective market capitalizations stand at $612.8B and $1.20T. Johnson & Johnson is headquartered in United States and Samsung Electronics Co., Ltd. operates from South Korea, and those different home markets shape how each company competes.

Johnson & Johnson: Johnson & Johnson began as a medical-products company in the nineteenth century and became a diversified healthcare giant. After the Kenvue separation, it is a more focused healthcare company centered on medicine and medical technology.

Samsung Electronics Co., Ltd.: Samsung is unusually broad for a technology company. It is a national industrial champion, a memory supplier, a smartphone competitor, a display maker, an appliance company, and an automotive electronics owner through Harman. That breadth is both the moat and the management challenge.

Johnson & Johnson and Samsung Electronics Co., Ltd. pursue distinct approaches to generating revenue, and understanding how each company operates is the foundation of any fair comparison between Johnson & Johnson and Samsung Electronics Co., Ltd..

Johnson & Johnson business model: Johnson & Johnson makes money by discovering, developing, manufacturing, and selling prescription medicines and medical technologies. Innovative Medicine sells therapies in oncology, immunology, neuroscience, pulmonary hypertension, infectious disease, and cardiovascular/metabolism. MedTech sells surgery, orthopaedics, cardiovascular, and vision products to hospitals, physicians, and healthcare systems.

Samsung Electronics Co., Ltd. business model: Samsung earns revenue from memory semiconductors including DRAM, NAND, and HBM; system LSI and foundry; Galaxy smartphones and tablets; display panels; TVs and appliances; network equipment; and Harman automotive and audio products. Memory cycles often drive profits even when smartphones drive brand visibility.

The durability of a company's moat often decides long-term winners. Here is how the competitive advantages of Johnson & Johnson stack up against those of Samsung Electronics Co., Ltd..

Johnson & Johnson competitive advantage: Johnson & Johnson's advantage comes from scale, R&D depth, global regulatory capability, major oncology and immunology franchises, MedTech breadth, and a large commercial infrastructure.

Samsung Electronics Co., Ltd. competitive advantage: Samsung advantage is vertical integration across memory, displays, processors, devices, appliances, and manufacturing. It can supply components to competitors while also using those components in its own Galaxy devices and consumer electronics ecosystem.

Future prospects matter as much as current results. The growth strategies below explain how Johnson & Johnson and Samsung Electronics Co., Ltd. each plan to expand from here.

Johnson & Johnson growth strategy: The company is investing in oncology, immunology, neuroscience, cardiovascular MedTech, electrophysiology, surgery, R&D, acquisitions, and global commercial execution.

Samsung Electronics Co., Ltd. growth strategy: Samsung growth strategy is built around AI memory, HBM3E and HBM4, advanced packaging, 3nm and next-generation foundry nodes, Galaxy AI devices, premium OLED and TV products, connected appliances, networks, and Harman automotive electronics.

A closer look at the financial trajectory of Johnson & Johnson and Samsung Electronics Co., Ltd. rounds out the comparison.

Johnson & Johnson: Johnson & Johnson's FY2025 sales increased 6.0% to $94.193 billion. Net earnings rose to $26.804 billion, helped by operating performance and other income items. Innovative Medicine generated $60.401 billion in sales, while MedTech generated $33.792 billion.

Samsung Electronics Co., Ltd.: Samsung reported KRW 333.6 trillion in 2025 annual revenue and KRW 43.6 trillion in operating profit. Fourth-quarter revenue reached KRW 93.8 trillion, the highest quarterly consolidated revenue in company history, and fourth-quarter operating profit was KRW 20.1 trillion.